Shanghai Allist Pharmaceuticals Co. Ltd. A (688578): Kapitalflussrechnung
| Preis (11.09.2026) | 52W Hoch | 52W Tief |
| 99,49 Renminbi Yuan | 137,535 Renminbi Yuan | 78,384 Renminbi Yuan |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 38 Renminbi Yuan | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 450.000.000 | - | - |
Kennzahl in 1000 CNY | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|
Umsatz | 5.171.705,6 | 3.557.930,155 | 2.018.182,563 | 791.002,453 | 530.094,158 | 560,887 | 629,723 | 4.619,965 | 7.727 |
Cashflow aus operativer Geschäftstätigkeit | 2.322.531,541 | 1.566.013,458 | 674.649,763 | 91.629,612 | 29.291,072 | -196.745,031 | -259.373,947 | -97.254,545 | 10.112,161 |
▸ Operative Cashflow Marge | 44,91% | 44,01% | 33,43% | 11,58% | 5,53% | -35.077,48% | -41.188,58% | -2.105,09% | 130,87% |
Investitionsausgaben (CapEx) | 186.002,846 | 270.218,351 | 67.882,336 | 143.834,91 | 192.245,47 | 88.454,587 | 89.366,29 | 35.985,17 | 1.395,341 |
Cashflow aus Investitionstätigkeit | - | -1.835.169,244 | 92.751,516 | -404.214,182 | 239.185,443 | -1.742.782,232 | -622.420,706 | 39.167,532 | -17.034,078 |
Cashflow aus Finanzierungstätigkeit | - | -295.045,899 | -2.206,235 | -3.685,885 | -16.966,645 | 1.913.136,262 | 1.152.473,039 | 122.145,955 | -11.256,266 |
Freier Cashflow | 2.136.528,695 | 1.295.795,107 | 606.767,427 | -52.205,298 | -162.954,398 | -285.199,618 | -348.740,237 | -133.239,715 | 8.716,82 |
▸ Freie Cashflow Marge | 41,31% | 36,42% | 30,07% | -6,6% | -30,74% | -50.847,96% | -55.379,94% | -2.884% | 112,81% |
Ausgeschüttete Dividenden | -360.000 | -292.500 | - | - | - | -1.190,138 | -33.380,896 | -4.500,11 | -4.256,266 |
Neuausgabe und Rückkäufe von Stammaktien | - | - | - | - | - | - | - | - | - |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.